Mohammad Rashidian, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staining and Labeling | 6 | 2021 | 1080 | 1.120 |
Why?
|
Oximes | 5 | 2015 | 303 | 0.990 |
Why?
|
Alkyl and Aryl Transferases | 5 | 2022 | 89 | 0.940 |
Why?
|
Positron-Emission Tomography | 11 | 2024 | 6669 | 0.910 |
Why?
|
Molecular Imaging | 3 | 2021 | 826 | 0.880 |
Why?
|
Aminoacyltransferases | 2 | 2021 | 52 | 0.860 |
Why?
|
Pemphigus | 2 | 2021 | 107 | 0.830 |
Why?
|
Cysteine Endopeptidases | 2 | 2021 | 542 | 0.740 |
Why?
|
Immunologic Techniques | 1 | 2021 | 213 | 0.720 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.650 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2020 | 4648 | 0.600 |
Why?
|
Aldehydes | 4 | 2022 | 170 | 0.600 |
Why?
|
Lymphopenia | 1 | 2020 | 300 | 0.580 |
Why?
|
Immobilized Proteins | 3 | 2015 | 24 | 0.560 |
Why?
|
Polyisoprenyl Phosphates | 2 | 2013 | 38 | 0.540 |
Why?
|
Hydrazones | 3 | 2015 | 105 | 0.530 |
Why?
|
Phenylenediamines | 2 | 2015 | 89 | 0.530 |
Why?
|
Enzymes | 2 | 2013 | 254 | 0.480 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2017 | 506 | 0.460 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1512 | 0.460 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1230 | 0.450 |
Why?
|
Green Fluorescent Proteins | 3 | 2015 | 2065 | 0.450 |
Why?
|
Ciliary Neurotrophic Factor | 1 | 2013 | 77 | 0.440 |
Why?
|
Sesquiterpenes | 2 | 2013 | 176 | 0.430 |
Why?
|
Immunotherapy | 7 | 2022 | 4754 | 0.400 |
Why?
|
Tumor Microenvironment | 7 | 2022 | 3948 | 0.380 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1996 | 0.370 |
Why?
|
Bacterial Proteins | 2 | 2021 | 3840 | 0.350 |
Why?
|
Protein Prenylation | 4 | 2015 | 70 | 0.340 |
Why?
|
Immune System | 1 | 2015 | 800 | 0.330 |
Why?
|
T-Lymphocytes | 3 | 2024 | 10266 | 0.330 |
Why?
|
Aspartame | 1 | 2008 | 19 | 0.320 |
Why?
|
Melanoma, Experimental | 4 | 2021 | 559 | 0.310 |
Why?
|
Neoplasms | 8 | 2022 | 22371 | 0.300 |
Why?
|
Copper | 1 | 2010 | 368 | 0.300 |
Why?
|
Diagnostic Imaging | 2 | 2021 | 3533 | 0.290 |
Why?
|
Immunoglobulin Fragments | 2 | 2018 | 84 | 0.290 |
Why?
|
Antigens | 3 | 2024 | 1443 | 0.290 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3604 | 0.280 |
Why?
|
Sweetening Agents | 1 | 2008 | 290 | 0.260 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2020 | 757 | 0.220 |
Why?
|
Terpenes | 2 | 2015 | 102 | 0.210 |
Why?
|
Papillomaviridae | 2 | 2020 | 1140 | 0.210 |
Why?
|
Ankyrin Repeat | 1 | 2022 | 19 | 0.210 |
Why?
|
Proteins | 3 | 2022 | 6009 | 0.210 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2017 | 1441 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.200 |
Why?
|
Mice | 15 | 2024 | 82049 | 0.200 |
Why?
|
Neoplasm Transplantation | 2 | 2017 | 2014 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6395 | 0.190 |
Why?
|
Acute Generalized Exanthematous Pustulosis | 1 | 2021 | 14 | 0.190 |
Why?
|
Gold | 2 | 2022 | 488 | 0.190 |
Why?
|
Monitoring, Immunologic | 1 | 2021 | 100 | 0.190 |
Why?
|
Animals | 22 | 2024 | 169285 | 0.180 |
Why?
|
Histological Techniques | 1 | 2021 | 194 | 0.180 |
Why?
|
Cytokines | 3 | 2021 | 7452 | 0.180 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2021 | 4415 | 0.170 |
Why?
|
Spectrum Analysis, Raman | 1 | 2022 | 253 | 0.170 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6975 | 0.160 |
Why?
|
Polyethylene Glycols | 3 | 2015 | 1197 | 0.160 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2021 | 219 | 0.160 |
Why?
|
Models, Molecular | 4 | 2015 | 5402 | 0.160 |
Why?
|
Peptides | 1 | 2010 | 4354 | 0.150 |
Why?
|
Metal Nanoparticles | 1 | 2022 | 406 | 0.150 |
Why?
|
Orthomyxoviridae Infections | 1 | 2020 | 255 | 0.150 |
Why?
|
Protein Engineering | 1 | 2021 | 553 | 0.150 |
Why?
|
Radionuclide Imaging | 1 | 2021 | 2000 | 0.140 |
Why?
|
Influenza A virus | 1 | 2020 | 460 | 0.140 |
Why?
|
Substrate Specificity | 4 | 2015 | 1751 | 0.130 |
Why?
|
Glucose | 1 | 2008 | 4352 | 0.130 |
Why?
|
Adipocytes, Brown | 1 | 2017 | 160 | 0.130 |
Why?
|
Organ Specificity | 1 | 2021 | 1968 | 0.130 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2018 | 287 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1105 | 0.120 |
Why?
|
Freund's Adjuvant | 1 | 2015 | 144 | 0.120 |
Why?
|
Nanotechnology | 1 | 2020 | 714 | 0.120 |
Why?
|
Catalysis | 2 | 2015 | 768 | 0.120 |
Why?
|
Copper Radioisotopes | 1 | 2015 | 100 | 0.120 |
Why?
|
Half-Life | 1 | 2015 | 651 | 0.120 |
Why?
|
Immunity | 1 | 2020 | 1003 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 372 | 0.110 |
Why?
|
Dimerization | 1 | 2015 | 887 | 0.110 |
Why?
|
Indicators and Reagents | 1 | 2015 | 456 | 0.110 |
Why?
|
Mice, Inbred C57BL | 8 | 2021 | 22380 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3740 | 0.100 |
Why?
|
Luminescent Proteins | 1 | 2015 | 838 | 0.100 |
Why?
|
Cell Line, Tumor | 5 | 2022 | 17142 | 0.100 |
Why?
|
Cell Extracts | 1 | 2013 | 135 | 0.100 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2015 | 648 | 0.100 |
Why?
|
Fluorine Radioisotopes | 1 | 2015 | 425 | 0.100 |
Why?
|
Bone Marrow Cells | 2 | 2020 | 2414 | 0.100 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2012 | 69 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2211 | 0.100 |
Why?
|
Adipose Tissue, Brown | 1 | 2017 | 776 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1738 | 0.090 |
Why?
|
Hydrazines | 1 | 2013 | 223 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2019 | 5442 | 0.090 |
Why?
|
Azides | 1 | 2010 | 120 | 0.090 |
Why?
|
Biocatalysis | 1 | 2010 | 168 | 0.090 |
Why?
|
Myeloid Cells | 1 | 2015 | 839 | 0.090 |
Why?
|
Alkynes | 1 | 2010 | 326 | 0.080 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2012 | 414 | 0.080 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 267 | 0.080 |
Why?
|
Molecular Structure | 1 | 2013 | 1884 | 0.080 |
Why?
|
Humans | 19 | 2024 | 768171 | 0.080 |
Why?
|
Flow Cytometry | 2 | 2017 | 5902 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1756 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4793 | 0.070 |
Why?
|
Antibodies | 1 | 2015 | 2421 | 0.070 |
Why?
|
Thermodynamics | 1 | 2008 | 591 | 0.070 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 1640 | 0.060 |
Why?
|
Macrophages | 1 | 2021 | 5802 | 0.060 |
Why?
|
Escherichia coli | 2 | 2022 | 4213 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1966 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2017 | 3080 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 3049 | 0.060 |
Why?
|
Breast Neoplasms | 3 | 2020 | 21207 | 0.050 |
Why?
|
Mice, Knockout | 4 | 2021 | 14488 | 0.050 |
Why?
|
Disease Progression | 1 | 2020 | 13668 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5706 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18349 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5863 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13422 | 0.050 |
Why?
|
Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2020 | 19 | 0.050 |
Why?
|
Single-Chain Antibodies | 1 | 2021 | 114 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17623 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8747 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2015 | 19025 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 306 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 30009 | 0.040 |
Why?
|
Female | 9 | 2021 | 397187 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 960 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2735 | 0.040 |
Why?
|
Primates | 1 | 2020 | 520 | 0.040 |
Why?
|
Camelids, New World | 1 | 2017 | 20 | 0.040 |
Why?
|
Signal Transduction | 1 | 2020 | 23648 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4568 | 0.040 |
Why?
|
Proteomics | 1 | 2010 | 3912 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 2018 | 342 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2300 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2020 | 682 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10873 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2020 | 4168 | 0.030 |
Why?
|
Computer Simulation | 1 | 2008 | 6283 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1377 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17569 | 0.030 |
Why?
|
Biochemistry | 1 | 2015 | 116 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2527 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2020 | 1361 | 0.030 |
Why?
|
HIV Antibodies | 1 | 2021 | 1341 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1219 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2021 | 9262 | 0.030 |
Why?
|
Behavior, Animal | 1 | 2020 | 1862 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2474 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13677 | 0.020 |
Why?
|
Fibrosis | 1 | 2019 | 2081 | 0.020 |
Why?
|
Cholesterol | 1 | 2020 | 2914 | 0.020 |
Why?
|
Nanoparticles | 1 | 2022 | 1986 | 0.020 |
Why?
|
Quantum Theory | 1 | 2010 | 68 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1040 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 283 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 65379 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5028 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6231 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2010 | 699 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3409 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5789 | 0.020 |
Why?
|
Apoptosis | 1 | 2022 | 9527 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2830 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9343 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10478 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2013 | 1931 | 0.010 |
Why?
|
HeLa Cells | 1 | 2010 | 3074 | 0.010 |
Why?
|
HIV-1 | 1 | 2021 | 6963 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11930 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9497 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10101 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23782 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20225 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15602 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2019 | 11101 | 0.010 |
Why?
|
Male | 2 | 2019 | 364731 | 0.010 |
Why?
|